Océanie · Actualité générale · The Courier-Mail

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

Publié par The Courier-Mail · Australie il y a 9 h

A review of blinded data from Recce Pharmaceuticals’ Phase III trial in Indonesia of RECCE 327 Gel (R327G) in diabetic foot infections (DFIs) by clinical experts and a…

Lire l'article complet sur The Courier-Mail Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.couriermail.com.au)

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

À lire aussi

Most of WA’s mega-university merger panel have ties to this one university

Pakistani army chief arrives in Iran for mediation

Bavuma leads fightback with gritty ton

Bavuma leads fightback with gritty ton

‘Chasing a trophy’: Chiefs reveal bold ambition for debut NRL season

New Zealand’s sole Melbourne Cup contender Manzor Blue may take detour today

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

Partager

À lire aussi

Most of WA’s mega-university merger panel have ties to this one university

Pakistani army chief arrives in Iran for mediation

Bavuma leads fightback with gritty ton

Bavuma leads fightback with gritty ton

‘Chasing a trophy’: Chiefs reveal bold ambition for debut NRL season

New Zealand’s sole Melbourne Cup contender Manzor Blue may take detour today